Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

  • Hungria, Vania M.D., Ph.D.
  • Mateos, María-Victoria M.D., Ph.D.

  • 1Clinica São Germano, São Paulo, Brazil

    2Hospital Universitario de Salamanca, Salamanca, Spain [email protected]

Since publication of the article, the authors report no further potential conflict of interest.

New England Journal of Medicine 391(14):p 1364-1365, October 10, 2024.
Copyright © 2024 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF

Related Articles